Lithium-related medication problems on nonpsychiatric inpatient medical units

2019 ◽  
Vol 76 (Supplement_4) ◽  
pp. S96-S101 ◽  
Author(s):  
Jennifer N Alastanos ◽  
Teresa G Potter ◽  
Ericka L Crouse

Abstract Purpose Results of a study of medication-related problems (MRPs) associated with lithium use on nonpsychiatric inpatient medical units are reported. Methods In a single-center, retrospective study, the records of all patients hospitalized over a 21-month period who received lithium or had a documented serum lithium concentration during hospitalization were evaluated. The primary objective was to identify patient-specific factors associated with lithium MRPs on nonpsychiatric inpatient medical units. Secondary objectives included characterization of lithium MRPs. Identified MRP occurrences were further evaluated to determine if an intervention was necessary to resolve the MRP and whether or not an intervention was made. Results A total of 150 patients were included in the study sample. One or more lithium MRPs were identified in 85% of the patients, with a total of 255 lithium MRPs identified. None of the patient-specific factors analyzed were significantly associated with MRP occurrence. Of the 128 patients in whom a lithium MRP occurred, 92.2% (n = 118) were judged to be appropriate candidates for interventions as defined per the study definitions; among those 118 patients, such interventions were documented for only 40.7% (n = 48). Conclusion Lithium MRPs were found to have occurred frequently on nonpsychiatric inpatient medical units at 1 hospital. Laboratory test– related MRPs and drug–drug interactions were the most commonly identified types of MRPs. Interventions to address MRPs were not made in the majority of patients; however, interventions were more frequently made when psychiatry consultation was involved.

2020 ◽  
Vol 9 (1) ◽  
Author(s):  
Heather Dorich ◽  
Jayne Pawasauskas ◽  
Britny Rogala ◽  
Kate Lally

Objective Depression has historically been an underdiagnosed and undertreated condition with a large impact on patient quality of life. Screening and diagnosis of depression may differ for various reasons, making proper diagnosis and treatment difficult. Methods In this retrospective cohort study, we analyzed the associations between the prevalence of depression and patient-specific factors in gynecologic and breast cancer patients who had received a palliative care consult. This study was conducted in a single institution that specializes in women and infant care. The primary objective was to quantify the prevalence of depression among palliative care patients. The secondary objective was to determine patient specific factors associated with a diagnosis of depression. Results Over the course of the one year inclusion period, a total of 73 patients met inclusion criteria. The prevalence of depression in this study was found to be 54.8%. A diagnosis of anxiety was associated with the presence of depression (77.5% vs 25%, p < 0. 0001). Cancer of the fallopian tube was also independently associated with depression (12. 5% vs 0, p = 0. 44). Conclusion The prevalence of depression for palliative care patients, specifically for patients with gynecologic and breast malignancies, in this study was higher than estimates of depression prevalence for the general population. The results of this study may indicate that a greater awareness of the need for screening and treatment of depression is necessary in this population, in order to properly diagnose and treat patients with depression.


Neurosurgery ◽  
2015 ◽  
Vol 77 (2) ◽  
pp. 157-163 ◽  
Author(s):  
Silky Chotai ◽  
Ahilan Sivaganesan ◽  
Scott L. Parker ◽  
Matthew J. McGirt ◽  
Clinton J. Devin

2021 ◽  
Vol 13 ◽  
pp. 175628722199330
Author(s):  
Derry Minyao Ng ◽  
Maria Haleem ◽  
Anny Mamuchashvili ◽  
Kai-yun Wang ◽  
Jin-Feng Pan ◽  
...  

Treatment of urolithiasis depends on several important factors which include stone location, size, composition, and patient symptoms. Although significant advancements have been made in the surgical management of urolithiasis in the last decade, pharmacotherapy which can prevent the formation of new stones and decrease the recurrence of urolithiasis has not experienced the same level of success. Currently, urolithiasis is regarded as a complicated syndrome that is determined by numerous factors, and any treatment plan for urolithiasis should be individualized while considering any potential damage arising from stone-forming factors. This review introduces the most popular methods currently used to evaluate urolithiasis and the pharmacotherapy of urolithiasis based on patient-specific factors.


2015 ◽  
Vol 14 (1) ◽  
pp. 58-63 ◽  
Author(s):  
Sergio Hoyos ◽  
Jorge Escobar ◽  
Doris Cardona ◽  
Carlos Guzmán ◽  
Alvaro Mena ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document